13F-HR filed by Nextech Invest Ltd.
Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 15 holding rows worth $2,107,306,424.
- Accession
- 0001595430-26-000010
- Filer
- CIK 1595430
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 16 entries on the cover page, a total value of $2,107,306,424 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,107,306,424 with VALUE read as dollars as filed, 13F file number 028-25607. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 7,601,087 | $1,423,531,573 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 4,663,176 | $127,631,127 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 6,776,506 | $126,788,427 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 3,553,585 | $113,501,505 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 3,540,998 | $99,643,684 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 7,162,637 | $77,571,359 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 278,896 | $31,981,004 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,113,946 | $29,118,548 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 761,153 | $18,419,903 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,122,713 | $17,119,965 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 4,449,932 | $16,687,245 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 952,400 | $10,457,352 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 450,000 | $6,723,000 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,419,355 | $4,109,581 | dollars as filed | |
| ENGENE THERAPEUTICS INC | 29286X101 | COM | 2,324,943 | $4,022,151 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001595430-26-000010 | this filing | 2026-08-14 | acceptance time not in the bulk data set |